The Lithistida: Important sources of compounds useful in biomedical research

Current Opinion in Biotechnology

Volumn 21, Issue 6, 2010, Pages 801-807

  Wright, Amy E ^a  

^a FLORIDA ATLANTIC UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL ACTIVITIES; BIOLOGICAL MARKERS; BIOMEDICAL RESEARCH; NATURAL PRODUCTS;

6 EPI DICTYOSTATIN 1; 9 METHOXY DERIVATIVE; 9 METHOXY DOUBLE HYBRID; BETA TUBULIN; BISTHEONELLIDE A; CALLIPELTIN A; CALYCULIN A; DICTYOSTATIN 1; DISCODERMOLIDE; ERGOSTEROL; KABIRAMIDE C ACETATE; KABIRAMIDE DERIVATIVE; NATURAL PRODUCT; NEOPELTOLIDE; PACLITAXEL; PAPUAMIDE A; SWINHOLIDE A; THEOPALAUAMIDE; THEOPALAUANAMIDE; UNCLASSIFIED DRUG;

ANTIFUNGAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; BREAST CANCER; CLINICAL TRIAL; DRUG BINDING SITE; DRUG EFFICACY; DRUG ISOLATION; DRUG POTENCY; DRUG POTENTIATION; DRUG PROTEIN BINDING; DRUG SAFETY; DRUG SELECTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TARGETING; GLAUCOMA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; LITHISTIDA; MICROTUBULE ASSEMBLY; NONHUMAN; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; REVIEW; SOLID TUMOR; SPONGE (PORIFERA); STRUCTURE ACTIVITY RELATION; TREATMENT DURATION; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; WOUND; WOUND FIBROSIS;

ANIMALS; BIOLOGICAL PRODUCTS; BIOMEDICAL RESEARCH; MOLECULAR STRUCTURE; PORIFERA;

LITHISTIDA;

EID: 78349310074     PISSN: 09581669     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.copbio.2010.09.012     Document Type: Review

References (48)

1. Kelly-Borges M., Pomponi S.A. Phylogeny and classification of lithistid sponges (porifera: Demospongiae): a preliminary assessment using ribosomal DNA sequence comparisons. Mol Mar Biol Biotechnol 1994, 3:87-103.
2. Bewley C.A., Faulkner D.J. Lithistid sponges: star performers or hosts to the stars. Angew Chem Int Ed 1998, 37:2163-2178.
3. D'Auria M.V., Zampella A., Zollo F. The chemistry of lithistid sponge: a spectacular source of new metabolites. Stud Nat Prod Chem 2002, 26:1175-1258.
4. Bewley C.A., Holland N.D., Faulkner D.J. Two classes of metabolites from Theonella swinhoei are localized in distinct populations of bacterial symbionts. Experientia 1996, 52:716-722.
5. Piel J., Hui D., Wen G., Butzke D., Platzer M., Fusetani N., Matsunaga S. Antitumor polyketide biosynthesis by an uncultivated bacterial symbiont of the marine sponge Theonella swinhoei. Proc Natl Acad Sci USA 2004, 101:16222-16227.
6. Piel J., Butzke D., Fusetani N., Hui D., Platzer M., Wen G., Matsunaga S. Exploring the chemistry of uncultivated bacterial symbionts: antitumor polyketides of the pederin family. J Nat Prod 2005, 68:472-479.
7. Uria A., Piel J. Cultivation-independent approaches to investigate the chemistry of marine symbiotic bacteria. Phytochem Rev 2009, 8:401-414.
8. Kato Y., Fusetani N., Matsunaga S., Hashimoto K., Fujita S., Furuya T. Bioactive marine metabolites. Part 16. Calyculin A. A novel antitumor metabolite from the marine sponge Discodermia calyx. J Am Chem Soc 1986, 108:2780-2781.
9. Ishihara H., Martin B.L., Brautigan D.L., Karaki H., Ozaki H., Kato Y., Fusetani N., Watabe S., Hashimoto K., Uemura D., et al. Calyculin A and okadaic acid: inhibitors of protein phosphatase activity. Biochem Biophys Res Commun 1989, 159:871-877.
10. Fagerholm A.E., Habrant D., Koskinen A.M. Calyculins and related marine natural products as serine-threonine protein phosphatase PP1 and PP2A inhibitors and total syntheses of calyculin A, B, and C. Mar Drugs 2010, 8:122-172.
11. Wegerski C.J., Hammond J., Tenney K., Matainaho T., Crews P. A serendipitous discovery of isomotuporin-containing sponge populations of Theonella swinhoei. J Nat Prod 2007, 70:89-94.
12. Carmely S., Kashman Y. Structure of swinholide-A, a new macrolide from the marine sponge Theonella swinhoei. Tetrahedron Lett 1985, 26:511-514.
13. Kato Y., Fusetani N., Matsunaga S., Hashimoto K., Sakai R., Higa T., Kashman Y. Antitumor macrodiolides isolated from a marine sponge sp.: Structure revision of misakinolide A. Tetrahedron Lett 1987, 28:6225-6228.
14. Bubb M.R., Spector I., Bershadsky A.D., Korn E.D. Swinholide A is a microfilament disrupting marine toxin that stabilizes actin dimers and severs actin filaments. J Biol Chem 1995, 270:3463-3466.
15. Saito S.Y., Watabe S., Ozaki H., Kobayashi M., Suzuki T., Kobayashi H., Fusetani N., Karaki H. Actin-depolymerizing effect of dimeric macrolides, bistheonellide A and swinholide A. J Biochem 1998, 123:571-578.
16. Spector I., Braet F., Shochet N.R., Bubb M.R. New anti-actin drugs in the study of the organization and function of the actin cytoskeleton. Microsc Res Tech 1999, 47:18-37.
17. Klenchin V.A., Allingham J.S., King R., Tanaka J., Marriott G., Rayment I. Trisoxazole macrolide toxins mimic the binding of actin-capping proteins to actin. Nat Struct Biol 2003, 10:1058-1063.
18. Allingham J.S., Zampella A., D'Auria M.V., Rayment I. Structures of microfilament destabilizing toxins bound to actin provide insight into toxin design and activity. Proc Natl Acad Sci USA 2005, 102:14527-14532.
19. Ho C.H., Magtanong L., Barker S.L., Gresham D., Nishimura S., Natarajan P., Koh J.L., Porter J., Gray C.A., Andersen R.J., et al. A molecular barcoded yeast ORF library enables mode-of-action analysis of bioactive compounds. Nat Biotechnol 2009, 27:369-377.
20. Schmidt E.W., Bewley C.A., Faulkner D.J. Theopalauamide, a bicyclic glycopeptide from filamentous bacterial symbionts of the lithistid sponge Theonella swinhoei from Palau and Mozambique. J Org Chem 1998, 63:1254-1258.
21. Nishimura S., Arita Y., Honda M., Iwamoto K., Matsuyama A., Shirai A., Kawasaki H., Kakeya H., Kobayashi T., Matsunaga S., et al. Marine antifungal theonellamides target 3beta-hydroxysterol to activate Rho1 signaling. Nat Chem Biol 2010, 6:519-526.
22. Andavan G.S., Lemmens-Gruber R. Cyclodepsipeptides from marine sponges: natural agents for drug research. Mar Drugs 2010, 8:810-834.
23. Andjelic C.D., Planelles V., Barrows L.R. Characterizing the anti-HIV activity of papuamide A. Mar Drugs 2008, 6:528-549.
24. Gunasekera S.P., Gunasekera M., Longley R.E., Schulte G.K. Discodermolide: a new bioactive polyhydroxylated lactone from the marine sponge Discodermia dissoluta. J Org Chem 1990, 55:4912-4915.
25. ter Haar E., Kowalski R.J., Hamel E., Lin C.M., Longley R.E., Gunasekera S.P., Rosenkranz H.S., Day B.W. Discodermolide, a cytotoxic marine agent that stabilizes microtubules more potently than taxol. Biochemistry 1996, 35:243-250.
26. Martello L.A., McDaid H.M., Regl D.L., Yang C.P., Meng D., Pettus T.R., Kaufman M.D., Arimoto H., Danishefsky S.J., Smith A.B., et al. Taxol and discodermolide represent a synergistic drug combination in human carcinoma cell lines. Clin Cancer Res 2000, 6:1978-1987.
27. Honore S., Kamath K., Braguer D., Horwitz S.B., Wilson L., Briand C., Jordan M.A. Synergistic suppression of microtubule dynamics by discodermolide and paclitaxel in non-small cell lung carcinoma cells. Cancer Res 2004, 64:4957-4964.
28. Huang G.S., Lopez-Barcons L., Freeze B.S., Smith A.B., Goldberg G.L., Horwitz S.B., McDaid H.M. Potentiation of taxol efficacy and by discodermolide in ovarian carcinoma xenograft-bearing mice. Clin Cancer Res 2006, 12:298-304.
29. Klein L.E., Freeze B.S., Smith A.B., Horwitz S.B. The microtubule stabilizing agent discodermolide is a potent inducer of accelerated cell senescence. Cell Cycle 2005, 4:501-507.
30. Smith A.B., Freeze B.S. (+)-Discodermolide: total synthesis, construction of novel analogues, and biological evaluation. Tetrahedron 2008, 64:261-298.
31. Paterson I., Florence G.J. The chemical synthesis of discodermolide. Top Curr Chem 2009, 286:73-119.
32. Smith A.B., Kaufman M.D., Beauchamp T.J., LaMarche M.J., Arimoto H. Gram-scale synthesis of (+)-discodermolide. Org Lett 1999, 1:1823-1826.
33. Mickel S.J. Total synthesis of the marine natural product (+)-discodermolide in multigram quantities. Pure Appl Chem 2007, 79:685-700.
34. Shaw S.J. The structure activity relationship of discodermolide analogues. Mini Rev Med Chem 2008, 8:276-284.
35. Jimenez-Barbero J., Amat-Guerri F., Snyder J.P. The solid state, solution and tubulin-bound conformations of agents that promote microtubule stabilization. Curr Med Chem Anticancer Agents 2002, 2:91-122.
36. Sanchez-Pedregal V.M., Kubicek K., Meiler J., Lyothier I., Paterson I., Carlomagno T. The tubulin-bound conformation of discodermolide derived by NMR studies in solution supports a common pharmacophore model for epothilone and discodermolide. Angew Chem Int Ed Engl 2006, 45:7388-7394.
37. Jogalekar A.S., Kriel F.H., Shi Q., Cornett B., Cicero D., Snyder J.P. The discodermolide hairpin structure flows from conformationally stable modular motifs. J Med Chem 2010, 53:155-165.
38. Khrapunovich-Baine M., Menon V., Verdier-Pinard P., Smith A.B., Angeletti R.H., Fiser A., Horwitz S.B., Xiao H. Distinct pose of discodermolide in taxol binding pocket drives a complementary mode of microtubule stabilization. Biochemistry 2009, 48:11664-11677.
39. Pettit G.R., Cichacz Z.A., Gao F., Boyd M.R., Schmidt J.M. Isolation and structure of the cancer cell growth inhibitor dictyostatin 1. J Chem Soc Chem Commun 1994, 9:1111-1112.
40. Isbrucker R.A., Cummins J., Pomponi S.A., Longley R.E., Wright A.E. Tubulin polymerizing activity of dictyostatin-1, a polyketide of marine sponge origin. Biochem Pharmacol 2003, 66:75-82.
41. Canales A., Matesanz R., Gardner N.M., Andreu J.M., Paterson I., Diaz J.F., Jimenez-Barbero J. The bound conformation of microtubule-stabilizing agents: NMR insights into the bioactive 3D structure of discodermolide and dictyostatin. Chemistry 2008, 14:7557-7569.
42. Pfeiffer B., Kuzniewski C.N., Wullschleger C., Altmann K.H. Macrolide-based microtubule-stabilizing agents-chemistry and structure-activity relationships. Top Curr Chem 2009, 286:1-72.
43. Eiseman J.L., Bai L., Jung W.-H., Moura-Letts G., Day B.W., Curran D.P. Improved synthesis of 6-epi-dictyostatin and antitumor efficacy in mice bearing MDA-MB231 human breast cancer xenografts. J Med Chem 2008, 51:6650-6653.
44. Paterson I., Naylor G.J., Fujita T., Guzman E., Wright A.E. Total synthesis of a library of designed hybrids of the microtubule-stabilising anticancer agents taxol, discodermolide and dictyostatin. Chem Commun (Camb) 2010, 46:261-263.
45. Plaza A., Bifulco G., Masullo M., Lloyd J.R., Keffer J.L., Colin P.L., Hooper J.N., Bell L.J., Bewley C.A. Mutremdamide A and koshikamides C-H, peptide inhibitors of HIV-1 entry from different Theonella species. J Org Chem 2010, 75:4344-4355.
46. Wada S., Matsunaga S., Saito S., Fusetani N., Watabe S. Actin-binding specificity of marine macrolide toxins, mycalolide B and kabiramide D. J Biochem 1998, 123:946-952.
47. Wright A.E., Botelho J.C., Guzman E., Harmody D., Linley P., McCarthy P.J., Pitts T.P., Pomponi S.A., Reed J.K. Neopeltolide, a macrolide from a lithistid sponge of the family Neopeltidae. J Nat Prod 2007, 70:412-416.
48. Ulanovskaya O.A., Janjic J., Suzuki M., Sabharwal S.S., Schumacker P.T., Kron S.J., Kozmin S.A. Synthesis enables identification of the cellular target of leucascandrolide A and neopeltolide. Nat Chem Biol 2008, 4:418-424.